FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:RFWD2-MSH4

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: RFWD2-MSH4
FusionPDB ID: 73678
FusionGDB2.0 ID: 73678
HgeneTgene
Gene symbol

RFWD2

MSH4

Gene ID

64326

4438

Gene nameCOP1 E3 ubiquitin ligasemutS homolog 4
SynonymsCFAP78|FAP78|RFWD2|RNF200-
Cytomap

1q25.1-q25.2

1p31.1

Type of geneprotein-codingprotein-coding
DescriptionE3 ubiquitin-protein ligase COP1E3 ubiquitin-protein ligase RFWD2RING finger protein 200RING-type E3 ubiquitin transferase RFWD2constitutive photomorphogenesis protein 1 homologconstitutive photomorphogenic protein 1putative ubiquitin ligase COP1rimutS protein homolog 4hMSH4
Modification date2020031320200313
UniProtAcc.

O15457

Main function of 5'-partner protein: FUNCTION: Involved in meiotic recombination. Required for reciprocal recombination and proper segregation of homologous chromosomes at meiosis.
Ensembl transtripts involved in fusion geneENST idsENST00000308769, ENST00000367669, 
ENST00000263187, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score17 X 15 X 10=25501 X 1 X 1=1
# samples 201
** MAII scorelog2(20/2550*10)=-3.6724253419715
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(1/1*10)=3.32192809488736
Fusion gene context

PubMed: RFWD2 [Title/Abstract] AND MSH4 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: RFWD2 [Title/Abstract] AND MSH4 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)RFWD2(176118142)-MSH4(76378381), # samples:2
Anticipated loss of major functional domain due to fusion event.RFWD2-MSH4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
RFWD2-MSH4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
RFWD2-MSH4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
RFWD2-MSH4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneRFWD2

GO:0010212

response to ionizing radiation

19805145



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:176118142/chr1:76378381)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across RFWD2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across MSH4 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000367669RFWD2chr1176118142-ENST00000263187MSH4chr176378381+188913465151537340
ENST00000308769RFWD2chr1176118142-ENST00000263187MSH4chr176378381+136281901010336

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000367669ENST00000263187RFWD2chr1176118142-MSH4chr176378381+0.0010369170.9989631
ENST00000308769ENST00000263187RFWD2chr1176118142-MSH4chr176378381+0.000715280.9992848

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for RFWD2-MSH4

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
RFWD2chr1176118142MSH4chr1763783811346277MEFLKVARRNKREQNQRSTPEMERQR
RFWD2chr1176118142MSH4chr176378381819273MEFLKVARRNKREQNQRSTPEMERQR

Top

Potential FusionNeoAntigen Information of RFWD2-MSH4 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
RFWD2-MSH4_176118142_76378381.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
RFWD2-MSH4chr1176118142chr176378381819HLA-B45:01REQNQRSTP0.98390.9061120
RFWD2-MSH4chr1176118142chr176378381819HLA-B50:02REQNQRSTP0.97450.57221120
RFWD2-MSH4chr1176118142chr176378381819HLA-B41:01REQNQRSTP0.77710.86751120
RFWD2-MSH4chr1176118142chr176378381819HLA-B50:01REQNQRSTP0.35220.71511120
RFWD2-MSH4chr1176118142chr176378381819HLA-B40:06REQNQRSTP0.99480.64371120
RFWD2-MSH4chr1176118142chr176378381819HLA-B50:04REQNQRSTP0.35220.71511120
RFWD2-MSH4chr1176118142chr176378381819HLA-B50:05REQNQRSTP0.35220.71511120
RFWD2-MSH4chr1176118142chr176378381819HLA-B41:03REQNQRSTPEM0.99320.59911122

Top

Potential FusionNeoAntigen Information of RFWD2-MSH4 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
RFWD2-MSH4_176118142_76378381.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
RFWD2-MSH4chr1176118142chr176378381819DRB1-0303MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1102MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1102EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1103MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1103EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1111MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1113MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1114MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1114EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1116MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1116EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1120MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1120EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1121MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1121EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1136MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1136EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1141MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1148MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1148EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1155MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1155EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1155FLKVARRNKREQNQR217
RFWD2-MSH4chr1176118142chr176378381819DRB1-1157MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1159MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1159EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1163MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1163EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1165MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1165EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1168MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1168EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1170MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1170EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1176MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1176EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1182MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1185MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1185EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1186MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1186EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1301MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1301EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1302MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1302EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1304MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1308MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1308EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1309MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1315MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1315EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1316MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1316EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1317MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1317EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1319MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1319EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1320MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1320EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1322MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1322EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1323MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1323EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1324MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1324EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1327MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1327EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1329MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1329EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1334MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1334EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1335MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1335EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1336MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1339MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1339EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1341MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1341EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1343MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1351MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1351EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1352MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1352EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1353MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1353EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1357MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1357EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1359MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1359EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1361MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1361EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1363MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1364MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1364EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1368MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1368EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1369MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1369EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1370MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1370EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1371MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1371EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1372MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1372EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1373MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1373EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1374MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1374EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1375MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1376MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1376EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1378MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1378EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1379MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1379EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1380MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1380EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1383MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1383EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1384MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1384EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1385MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1386MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1387MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1387EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1391MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1391EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1392MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1392EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1393MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1396MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1396EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1397MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1397EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1398MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1398EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1399MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1399EFLKVARRNKREQNQ116
RFWD2-MSH4chr1176118142chr176378381819DRB1-1412MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1418MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1421MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1424MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1429MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1433MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1437MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1464MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1472MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1481MEFLKVARRNKREQN015
RFWD2-MSH4chr1176118142chr176378381819DRB1-1495MEFLKVARRNKREQN015

Top

Fusion breakpoint peptide structures of RFWD2-MSH4

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
563ARRNKREQNQRSTPRFWD2MSH4chr1176118142chr176378381819

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of RFWD2-MSH4

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN563ARRNKREQNQRSTP-7.80278-7.97818
HLA-B14:023BVN563ARRNKREQNQRSTP-5.89568-6.70248
HLA-B52:013W39563ARRNKREQNQRSTP-7.43461-7.61001
HLA-B52:013W39563ARRNKREQNQRSTP-4.39436-5.20116
HLA-A11:014UQ2563ARRNKREQNQRSTP-8.18436-8.35976
HLA-A24:025HGA563ARRNKREQNQRSTP-8.79698-8.97238
HLA-A24:025HGA563ARRNKREQNQRSTP-6.45309-7.25989
HLA-B44:053DX8563ARRNKREQNQRSTP-7.34649-7.52189
HLA-B44:053DX8563ARRNKREQNQRSTP-6.59842-7.40522
HLA-A02:016TDR563ARRNKREQNQRSTP-3.10575-3.28115

Top

Vaccine Design for the FusionNeoAntigens of RFWD2-MSH4

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
RFWD2-MSH4chr1176118142chr1763783811120REQNQRSTPAGAGAGCAAAACCAAAGGAGTACCCCT
RFWD2-MSH4chr1176118142chr1763783811122REQNQRSTPEMAGAGAGCAAAACCAAAGGAGTACCCCTGAGATG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
RFWD2-MSH4chr1176118142chr176378381015MEFLKVARRNKREQNATGGAATTCCTCAAGGTTGCAAGAAGAAATAAGAGAGAGCAAAAC
RFWD2-MSH4chr1176118142chr176378381116EFLKVARRNKREQNQGAATTCCTCAAGGTTGCAAGAAGAAATAAGAGAGAGCAAAACCAA
RFWD2-MSH4chr1176118142chr176378381217FLKVARRNKREQNQRTTCCTCAAGGTTGCAAGAAGAAATAAGAGAGAGCAAAACCAAAGG

Top

Information of the samples that have these potential fusion neoantigens of RFWD2-MSH4

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
PRADRFWD2-MSH4chr1176118142ENST00000308769chr176378381ENST00000263187TCGA-YL-A8SF-01A

Top

Potential target of CAR-T therapy development for RFWD2-MSH4

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to RFWD2-MSH4

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to RFWD2-MSH4

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource